# South Texas Blood & Tissue Center – FDA Inspection, Dec 11, 2013

Source: https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/27da492a-4075-4886-873a-45e62d9362d8
Source feed: FDA_Inspections

> FDA inspection 860689 of South Texas Blood & Tissue Center, December 11, 2013. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. 12 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 860689
- Company Name: South Texas Blood & Tissue Center
- Inspection Date: 2013-12-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1279560 - 2025-08-14](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/eb0b438b-63e2-4a2c-862f-51cdae99b320)
- FDA Inspection 1172990 - 2022-06-09
- FDA Inspection 1122018 - 2020-02-20
- FDA Inspection 1117859 - 2020-02-14
- [FDA Inspection 1057467 - 2018-06-19](https://www.keypedia.com/records/fda_inspections/south-texas-blood-tissue-center/233db9fa-1f67-4545-bce9-b361d85018cd)

Company: https://www.keypedia.com/companies/south-texas-blood-tissue-center/f300c449-57f5-4e4b-b1b9-1ed80dc00c7e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d